Postpartum acquired haemophilia: a single centre experience with rituximab.
Dedeken
L
L
St-Louis
J
J
Demers
C
C
Meilleur
C
C
Rivard
G E
GE
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D005169:Factor VIII / Q000008:administration & dosage*; D005260:Female; D006467:Hemophilia A / Q000150:complications* / Q000628:therapy; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D006473:Postpartum Hemorrhage / Q000188:drug therapy / Q000209:etiology*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006490:Hemostatics; D007155:Immunologic Factors; D000069283:Rituximab; D005169:Factor VIII